Depixus

Depixus company information, Employees & Contact Information

Explore related pages

Related company profiles:

Depixus SAS, based in Paris, is a life science technology company pioneering a groundbreaking technology based on magnetic force spectroscopy. This innovative technology provides real-time analysis of individual biomolecular interactions at scale, enabling researchers to decode disease mechanisms and unlock faster routes to more effective therapies.

Company Details

Employees
53
Address
3-5 Impasse Reille, Paris,75014,france
Phone
+33 (0)9 72 48 20 89
Email
in****@****xus.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Paris
Looking for a particular Depixus employee's phone or email?

Depixus Questions

News

Depixus wins SLAS2024 Ignite Award for MAGNA™ technology - Business Wire

Depixus wins SLAS2024 Ignite Award for MAGNA™ technology Business Wire

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing - News-Medical

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing News-Medical

Depixus and Daiichi Sankyo Collaborate to Produce RNA-Targeted Drugs - Inside Precision Medicine

Depixus and Daiichi Sankyo Collaborate to Produce RNA-Targeted Drugs Inside Precision Medicine

Depixus Announces Strategic Collaboration With Daiichi Sankyo to Use MAGNA™ Technology to Accelerate RNA-targeted Drug Discovery - The AI Journal

Depixus Announces Strategic Collaboration With Daiichi Sankyo to Use MAGNA™ Technology to Accelerate RNA-targeted Drug Discovery The AI Journal

Depixus Announces Strategic Collaboration With Daiichi Sankyo to Use MAGNA™ Technology to Accelerate RNA-targeted Drug Discovery - Business Wire

Depixus Announces Strategic Collaboration With Daiichi Sankyo to Use MAGNA™ Technology to Accelerate RNA-targeted Drug Discovery Business Wire

Depixus Launches Technology Access Program With First MAGNA One™ Instrument Placement - Business Wire

Depixus Launches Technology Access Program With First MAGNA One™ Instrument Placement Business Wire

New Study Demonstrates Power of Depixus’ Scalable Single Molecule Interactomics Platform to Accelerate RNA-Targeted Drug Development - Business Wire

New Study Demonstrates Power of Depixus’ Scalable Single Molecule Interactomics Platform to Accelerate RNA-Targeted Drug Development Business Wire

Depixus to showcase unique single molecule technology solving the hit-to-lead challenge in RNA-targeted drug discovery at upcoming Discovery on Target Conference - Business Wire

Depixus to showcase unique single molecule technology solving the hit-to-lead challenge in RNA-targeted drug discovery at upcoming Discovery on Target Conference Business Wire

Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology - Business Wire

Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology Business Wire

Top Depixus Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant